FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 94 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $235 | -23.0% | 50 | 0.0% | 0.00% | – |
| Q2 2020 | $305 | -61.6% | 50 | -85.7% | 0.00% | – |
| Q1 2020 | $795 | +15.4% | 350 | +133.3% | 0.00% | – |
| Q4 2019 | $689 | +18.6% | 150 | 0.0% | 0.00% | – |
| Q3 2019 | $581 | -35.8% | 150 | 0.0% | 0.00% | – |
| Q2 2019 | $905 | -73.0% | 150 | -40.0% | 0.00% | – |
| Q1 2019 | $3,350 | +44.1% | 250 | 0.0% | 0.00% | – |
| Q4 2018 | $2,325 | -33.2% | 250 | 0.0% | 0.00% | – |
| Q3 2018 | $3,480 | -12.0% | 250 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $3,953 | -8.0% | 250 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $4,295 | – | 250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 115,500 | $2,531,000 | 0.89% |
| AWM Investment Company, Inc. | 150,000 | $3,288,000 | 0.64% |
| BB BIOTECH AG | 827,500 | $18,139,000 | 0.51% |
| Virtus ETF Advisers LLC | 17,371 | $381,000 | 0.48% |
| Rock Springs Capital Management LP | 425,000 | $9,316,000 | 0.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,728 | $9,880,000 | 0.39% |
| Telemetry Investments, L.L.C. | 44,176 | $968,000 | 0.37% |
| RTW INVESTMENTS, LP | 100,377 | $2,200,000 | 0.37% |
| Eventide Asset Management | 315,000 | $6,905,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 52,500 | $1,151,000 | 0.22% |